back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-12-05 16:31 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
Wildgoose Brown, Ian Craig
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-12,000 vol |
66,000 | |
| Filed 2025-12-05 16:30 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
Wildgoose Brown, Ian Craig
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+48,000 vol |
78,000 | |
| Filed 2025-12-05 16:28 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$21,215
+8,006 vol $2.65 each |
85,233 | |
| Filed 2025-12-05 16:27 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-8,006 vol |
72,000 | |
| Filed 2025-12-05 16:27 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-7,994 vol |
80,006 | |
| Filed 2025-12-05 16:25 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
Labelle, Richard
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+48,000 vol |
88,000 | |
| Filed 2025-12-05 16:24 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$47,700
+18,000 vol $2.65 each |
693,337 | |
| Filed 2025-12-05 16:23 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-18,000 vol |
123,342 | |
| Filed 2025-12-05 16:23 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-7,994 vol |
141,342 | |
| Filed 2025-12-05 16:22 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+56,001 vol |
149,336 | |
| Filed 2025-12-05 16:20 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,501
+6,227 vol $2.65 each |
89,538 | |
| Filed 2025-12-05 16:19 Tx date 2025-12-05 |
$MDP
Medexus Pharmaceuticals Inc. |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-6,227 vol |
68,000 | |
| Filed 2025-12-05 16:19 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-5,773 vol |
74,227 | |
| Filed 2025-12-05 16:17 Tx date 2025-12-01 |
$MDP
Medexus Pharmaceuticals Inc. |
Buschman, Brendon
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+48,000 vol |
80,000 | |
| Filed 2025-09-29 08:54 Tx date 2025-09-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$55,001
+18,457 vol $2.98 each |
42,869 | |
| Filed 2025-09-29 08:53 Tx date 2025-09-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-18,457 vol |
32,596 | |
| Filed 2025-09-29 08:52 Tx date 2025-09-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-20,649 vol |
51,053 | |
| Filed 2025-09-29 08:52 Tx date 2025-09-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Taddese, Menassie Mammo
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+32,596 vol |
71,702 | |
| Filed 2025-09-29 08:50 Tx date 2025-09-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Phelan, Nancy
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$55,001
+18,457 vol $2.98 each |
29,610 | |
| Filed 2025-09-29 08:49 Tx date 2025-09-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
Phelan, Nancy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-18,457 vol |
32,596 |